Incyte | INCY - Market Capitalization

Stock Price
99.64
Daily Change
-1.41 -1.40%
Monthly
-2.87%
Yearly
34.11%
Q1 Forecast
98.18

Incyte reported $22.69B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.09B 492M Feb/2026
Agenus USD 204M 164M Jun/2025
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Exelixis USD 12.27B 523M Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Ionis Pharmaceuticals USD 12.16B 652M Feb/2026
MacroGenics USD 114M 8M Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Nektar Therapeutics USD 113M 4M Sep/2023
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 1.77B 249M Feb/2026
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026